欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Streptococcus oralis Accessory Sec system protein translocase subunit SecY2 (secY2), partial CSB-YP516805FMU
CSB-EP516805FMU
CSB-BP516805FMU
CSB-MP516805FMU
CSB-EP516805FMU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella cf. novicida Epoxyqueuosine reductase (queG) CSB-YP516806FFB
CSB-EP516806FFB
CSB-BP516806FFB
CSB-MP516806FFB
CSB-EP516806FFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable aldo-keto reductase 6 (At1g60750) CSB-YP516807DOA
CSB-EP516807DOA
CSB-BP516807DOA
CSB-MP516807DOA
CSB-EP516807DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative B3 domain-containing protein At1g05615 (At1g05615) CSB-YP516808DOA
CSB-EP516808DOA
CSB-BP516808DOA
CSB-MP516808DOA
CSB-EP516808DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Rhodanese-like domain-containing protein 17 (STR17) CSB-YP516809DOA
CSB-EP516809DOA
CSB-BP516809DOA
CSB-MP516809DOA
CSB-EP516809DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative glucuronosyltransferase PGSIP7 (PGSIP7), partial CSB-YP516810DOA1
CSB-EP516810DOA1
CSB-BP516810DOA1
CSB-MP516810DOA1
CSB-EP516810DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative acyl-activating enzyme 19 (At5g35930), partial CSB-YP516811DOA
CSB-EP516811DOA
CSB-BP516811DOA
CSB-MP516811DOA
CSB-EP516811DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Solute carrier family 40 member 2 (IREG2), partial CSB-YP516812DOA
CSB-EP516812DOA
CSB-BP516812DOA
CSB-MP516812DOA
CSB-EP516812DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Batrachochytrium dendrobatidis Ubiquinol oxidase, mitochondrial (AOX), partial CSB-YP516813BSI1
CSB-EP516813BSI1
CSB-BP516813BSI1
CSB-MP516813BSI1
CSB-EP516813BSI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cytomegalovirus Putative viral CXC chemokine 2 (UL147) CSB-YP516814HWW
CSB-EP516814HWW
CSB-BP516814HWW
CSB-MP516814HWW
CSB-EP516814HWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cytomegalovirus Transcriptional regulator UL34 (UL34) CSB-YP516815HWW
CSB-EP516815HWW
CSB-BP516815HWW
CSB-MP516815HWW
CSB-EP516815HWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cytomegalovirus Membrane protein US14 (US14), partial CSB-YP516816HWW1
CSB-EP516816HWW1
CSB-BP516816HWW1
CSB-MP516816HWW1
CSB-EP516816HWW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cytomegalovirus Virion egress protein UL53 (UL53) CSB-YP516817HWW
CSB-EP516817HWW
CSB-BP516817HWW
CSB-MP516817HWW
CSB-EP516817HWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fulva Probable periplasmic serine endoprotease DegP-like (Psefu_3239) CSB-YP516818FFW
CSB-EP516818FFW
CSB-BP516818FFW
CSB-MP516818FFW
CSB-EP516818FFW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vitis vinifera tRNA (guanine (37)-N1)-methyltransferase 1, partial CSB-YP516819VFQ
CSB-EP516819VFQ
CSB-BP516819VFQ
CSB-MP516819VFQ
CSB-EP516819VFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus tropicalis Dynein assembly factor 3, axonemal (dnaaf3) CSB-YP516820XBF
CSB-EP516820XBF
CSB-BP516820XBF
CSB-MP516820XBF
CSB-EP516820XBF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ciona intestinalis 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase CSB-YP516821DTL
CSB-EP516821DTL
CSB-BP516821DTL
CSB-MP516821DTL
CSB-EP516821DTL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca mulatta ATP-dependent (S)-NAD (P)H-hydrate dehydratase, partial CSB-YP516822MOW
CSB-EP516822MOW
CSB-BP516822MOW
CSB-MP516822MOW
CSB-EP516822MOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Asterina pectinifera Scavenger receptor cysteine-rich domain superfamily protein (SRCR1), partial CSB-YP516823DPG
CSB-EP516823DPG
CSB-BP516823DPG
CSB-MP516823DPG
CSB-EP516823DPG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri NAD (P)H-hydrate epimerase CSB-YP516824LMU
CSB-EP516824LMU
CSB-BP516824LMU
CSB-MP516824LMU
CSB-EP516824LMU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細(xì)胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×